The new imaging agent offers a non-invasive method of detecting infection and monitoring antibiotic therapy.
Stanford University medical scientists have developed a novel imaging agent that could be used to identify most bacterial infections. The study is the featured basic science article in The Journal of Nuclear Medicine’s October issue.
Bacteria are good at mutating to become resistant to antibiotics. As one way to combat the problem of antimicrobial resistance, the Centers for Disease Control and Prevention (CDC) has called for the development of novel diagnostics to detect and help manage the treatment of infectious diseases.
“We really lack tools in the clinic to be able to visualize bacterial infections,” explains Sanjiv Sam Gambhir, MD, PhD, chair of the Radiology Department and director of Precision Health and Integrated Diagnostics at Stanford University in California. “What we need is something that bacteria eat that your cells, so-called mammalian cells, do not. As it turns out, there is such an agent, and that agent is maltose, which is taken up only by bacteria because they have a transporter, called a maltodextrine transporter, on their cell wall that is able to take up maltose and small derivatives of maltose.”
The traditional way of diagnosing bacterial infection involves biopsy of the infected tissue and/or blood and culture tests. Gambhir and colleagues developed a new positron emission tomography (PET) tracer, 6?-18F-fluoromaltotriose, that offers a non-invasive means of detection. The agent is a derivative of maltose and is labeled with radioactive fluorine-18 (18F). For this study, the tracer was evaluated in several clinically relevant bacterial strains in cultures and in mouse models using a micro-PET/CT scanner. Its use to help monitor antibiotic therapies was also evaluated in rats.
The results show that 6?-18F-fluoromaltotriose was taken up in both gram-positive and gram-negative bacterial strains, and it was able to detect Pseudomonas aeruginosa in a clinically relevant mouse model of wound infection.
Gambhir points out, “This is the first time this particular maltotriose, labeled with fluorine-18, has been synthesized and used in animal models. It’s able to pick up bacteria that may be present anywhere throughout your body, and it does not lead to an imaging signal from a site of infection that does not involve bacteria.”
He notes that the new agent even identified an infection in the heart of an animal. “We could pick up very small bacterial foci in a heart valve. And then when those animals were treated with an antibiotic, we could see that the signal went away in the heart. So, the properties of the tracer of sensitivity, specificity, low background signal throughout the animal are now facilitating its translation into humans.”
The results of this pre-clinical study demonstrate that 6?-18F-fluoromaltotriose is a promising new tracer for diagnosing most bacterial infections and has the potential to change the clinical management of patients suffering from infectious diseases of bacterial origin.
Looking ahead, Gambhir says, “The hope is that in the future when someone has a potential infection, this approach of injecting the patient with fluoromaltotriose and imaging them in a PET scanner will allow localization of the signal and, therefore, the bacteria. And then, as one treats them, one can verify that the treatment is actually working—so that if it’s not working, one can quickly change to a different treatment (for example, a different antibiotic). These kinds of findings are very important for patients, because they will very likely lead to entirely new ways to manage patients with bacterial infections, no matter where those infections might be hiding in the body.”
The Latest on: Bacterial infections
- Five babies are infected with a rare bacteria in Adelaideon June 2, 2020 at 11:30 pm
SA Health said two babies in the neonatal unit at the Flinders Medical Centre are symptomatic with Serratia marcescens, with one in a serious but stable condition.
- Five babies infected with rare bacteria at Flinders Medical Centre neonatal uniton June 2, 2020 at 11:20 pm
A rare bacteria has infected five babies at Adelaide's Flinders Medical Centre, with one in a serious condition as health authorities scramble to investigate the source of the outbreak.
- Five babies infected with rare bacteria in Adelaide hospitalon June 2, 2020 at 10:05 pm
Five babies have been infected by a rare bacteria in an Adelaide hospital, with one child in a serious condition.
- Bacteria that live in soil and on people have extensive antibiotic-destroying geneson June 2, 2020 at 9:47 pm
The latest generation of tetracyclines - a class of powerful, first-line antibiotics - was designed to thwart the two most common ways bacteria resist such drugs.
- Rare infection in babies in SA hospitalon June 2, 2020 at 9:44 pm
At least five babies in an Adelaide hospital have tested positive to a rare bacteria, with one in a serious but stable condition. SA Health says two babies ...
- Antibiotic-destroying genes widespread in bacteria in soil and on peopleon June 2, 2020 at 1:50 pm
Researchers at Washington University in St. Louis and the National Institutes of Health (NIH) have found that genes that confer the power to destroy tetracycline antibiotics are widespread in bacteria ...
- Beneficial bacteria prevent recurring bacterial vaginosison June 2, 2020 at 1:36 pm
An experimental treatment for a common infection called bacterial vaginosis significantly reduced the rates of recurrence.
- Does The Placenta Have A Bacterial Microbiome?on June 1, 2020 at 4:40 am
A 2014 study revealed the remarkable finding that the human placenta contains hundreds of bacteria species. 5 years later, two independent studies, each conducted with a more skeptical approach, ...
- With A Crash Course In Infection Prevention, The World Faces A New Normalon June 1, 2020 at 4:30 am
We must learn from this pandemic, instituting better protocols and procedures in order to prevent and better respond to future crises.
- Latest Research on Treating Common Bacterial Infections in Kids: A Short Summaryon May 29, 2020 at 11:35 am
An editorial published in conjunction with this new study reminds us not to assume that all of these children will improve regardless of empirical antibiotic begun. In fact, changing antibiotics to ...
via Google News and Bing News